Stocklytics Platform
Asset logo for symbol PDSB
PDS Biotechnology
PDSB44
$1.39arrow_drop_down2.11%-$0.03
Penny Stock
Asset logo for symbol PDSB
PDSB44

$1.39

arrow_drop_down2.11%

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•
•

PDS Biotechnology (PDSB) Stocklytics Forecast

PDS Biotechnology Corp (PDSB) is a biotechnology company that focuses on developing next-generation immunotherapies for various types of cancer. With its innovative approach to oncology treatments, the company has garnered significant attention from investors and analysts alike. As a result, many are eager to know what the future holds for PDSB stock.
In terms of price predictions, it is important to note that the stock market is inherently unpredictable, especially in the biotech sector. However, analysts and artificial intelligence (AI) algorithms can provide some insight into potential future trends. According to AI price prediction models, PDSB stock is expected to experience significant growth in the coming years. These models take into account various factors such as historical data, market trends, and company performance to generate forecasts.
add PDS Biotechnology to watchlist

Keep an eye on PDS Biotechnology

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

What is the analyst price prediction for PDS Biotechnology (PDSB) stock?

Analysts have set a target price of $18.86 for PDS Biotechnology (PDSB), based on forecasts from 21 analysts. The predicted price range extends from a high of $24 to a low of $8. This represents a potential increase of up to 1.63K% and a decrease of 475.54% from the current price of $1.39. These forecasts are as of 2019 Oct 24.
help

What are the analyst ratings for PDS Biotechnology (PDSB) stock?

The analyst ratings for PDS Biotechnology (PDSB) are distributed as follows: 6 analysts recommend buying, 0 have a neutral stance, and 0 suggest selling. There is a split consensus, with equal support for two of the rating categories. These ratings indicate the general sentiment among the analysts covering PDS Biotechnology.
help

What is the AI price prediction for PDS Biotechnology (PDSB) stock?

At present, there is no AI or machine-learning-based price prediction available for PDS Biotechnology (PDSB) stock. The lack of a forecast could stem from various factors, such as inadequate data or the necessity for model recalibration.

Take Your Investments to a Whole New Level